Insights

Global Expansion Relypsa, now Vifor Pharma, has successfully integrated and rebranded to expand its reach as a global leader in iron deficiency, nephrology, and cardio-renal therapies. This transition presents an opportunity to engage new markets and broaden the scope of potential sales.

Innovative Product Vifor Pharma's development of Veltassa® (patiromer) for oral suspension showcases its innovative approach rooted in polymer science. This unique product offering can be leveraged to attract healthcare providers looking for advanced treatment solutions, creating a sales advantage.

Tech-Savvy Operations With a tech stack including SAS, Python, and Cloudflare, Vifor Pharma demonstrates a commitment to leveraging technology for efficiency and excellence. Positioning its advanced tech capabilities in sales pitches can appeal to clients seeking partners with cutting-edge solutions.

Financial Stability Having secured $150M in funding, Vifor Pharma exhibits financial stability and growth potential. This positive financial standing can instill confidence in potential buyers, making it an opportune moment to present sales propositions for partnerships or product acquisitions.

Competitive Analysis Analyzing key competitors like Fresenius Medical Care and DaVita in the renal care industry can provide valuable insights for positioning Vifor Pharma strategically. By understanding market dynamics and competitor positioning, sales strategies can be tailored to capitalize on gaps and strengths in the market.

Similar companies to Relypsa

Relypsa Tech Stack

Relypsa uses 8 technology products and services including SAS, Cloudflare, Responsa, and more. Explore Relypsa's tech stack below.

SAS
Business Intelligence
Cloudflare
Content Management System
Responsa
Customer Service
Exhibit
Javascript Graphics
Informa
Miscellaneous
Microsoft Windows Server
Operating Systems
Python
Programming Languages
Concur
Travel And Expense Management

Media & News

Relypsa's Email Address Formats

Relypsa uses at least 2 format(s):

Relypsa Email Formats	Example	Percentage
FLast@relypsa.com	JDoe@relypsa.com	88%
Last@relypsa.com	Doe@relypsa.com	6%
FiLast@relypsa.com	JoDoe@relypsa.com	2%
First.Last@relypsa.com	John.Doe@relypsa.com	1%
LF@relypsa.com	DJ@relypsa.com	1%
LFirst@relypsa.com	DJohn@relypsa.com	1%
First@relypsa.com	John@relypsa.com	1%
First.Last@viforpharma.com	John.Doe@viforpharma.com	91%
FLast@viforpharma.com	JDoe@viforpharma.com	4%
Last.First@viforpharma.com	Doe.John@viforpharma.com	3%
First.Middle@viforpharma.com	John.Michael@viforpharma.com	2%

Frequently Asked Questions

Where is Relypsa's headquarters located?

Relypsa's main headquarters is located at 100 Cardinal Way Redwood City, CA 94063 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Relypsa's phone number?

You can contact Relypsa's main corporate office by phone at

+1-650-421-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Relypsa's stock symbol?

Relypsa is a publicly traded company; the company's stock symbol is RLYP.

What is Relypsa's official website and social media links?

Relypsa's official website is viforpharma.com and has social profiles on LinkedIn.

What is Relypsa's SIC code NAICS code?

Relypsa's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Relypsa have currently?

As of August 2023, Relypsa has approximately 201 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Dev. Officer And Sr. Vp: C. L.Vice President Clinical Development: M. M.Vice President Regulatory Affairs: Z. R.. Explore Relypsa's employee directory with LeadIQ.

What industry does Relypsa belong to?

Relypsa operates in the Biotechnology Research industry.

What technology does Relypsa use?

Relypsa's tech stack includes SASCloudflareResponsaExhibitInformaMicrosoft Windows ServerPythonConcur.

What is Relypsa's email format?

Relypsa's email format typically follows the pattern of . Find more Relypsa email formats with LeadIQ.

How much funding has Relypsa raised to date?

As of August 2023, Relypsa has raised $150M in funding. The last funding round occurred on May 03, 2016 for $150M.

When was Relypsa founded?

Relypsa was founded in 2007.

Relypsa

Biotechnology ResearchCalifornia, United States201-500 Employees

Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies. 

Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives.  We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science. 

Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones. 

(Our community guidelines: viforpharma.com/linkedin-cg)

Company Overview

Headquarters: 100 Cardinal Way Redwood City, CA 94063 US
Phone number: +1-650-421-****
Website: viforpharma.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: RLYP
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2007
Employees: 201-500